CD4 and myeloid sarcoma: The frequencies of circulating CD28+ CD27+, CD28+ CD27-, CD28- CD27+, and CD28- CD27- CD4+ T cells at the different maturation stages (naïve, CM, EM, and TEMRA) from patients with MS and controls did not show statistically significant differences either (Figure 1C).